PL176120B1 - Środek farmaceutyczny będący implantem podskórnym i sposób wytwarzania środka farmaceutycznego będącego implantem podskórnym. - Google Patents

Środek farmaceutyczny będący implantem podskórnym i sposób wytwarzania środka farmaceutycznego będącego implantem podskórnym.

Info

Publication number
PL176120B1
PL176120B1 PL93303780A PL30378093A PL176120B1 PL 176120 B1 PL176120 B1 PL 176120B1 PL 93303780 A PL93303780 A PL 93303780A PL 30378093 A PL30378093 A PL 30378093A PL 176120 B1 PL176120 B1 PL 176120B1
Authority
PL
Poland
Prior art keywords
methyl
norpregna
ori
active ingredient
oxo
Prior art date
Application number
PL93303780A
Other languages
English (en)
Polish (pl)
Inventor
Michel Lanquetin
Jean Louis Thomas
Jacques Paris
Elsimar Coutinho
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of PL176120B1 publication Critical patent/PL176120B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PL93303780A 1992-09-21 1993-09-17 Środek farmaceutyczny będący implantem podskórnym i sposób wytwarzania środka farmaceutycznego będącego implantem podskórnym. PL176120B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
PCT/FR1993/000900 WO1994006437A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives de nomegestrol

Publications (1)

Publication Number Publication Date
PL176120B1 true PL176120B1 (pl) 1999-04-30

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93303780A PL176120B1 (pl) 1992-09-21 1993-09-17 Środek farmaceutyczny będący implantem podskórnym i sposób wytwarzania środka farmaceutycznego będącego implantem podskórnym.

Country Status (31)

Country Link
US (1) US5565443A (enEXAMPLES)
EP (1) EP0613372B1 (enEXAMPLES)
JP (1) JPH08506318A (enEXAMPLES)
KR (1) KR100255700B1 (enEXAMPLES)
CN (1) CN1095667C (enEXAMPLES)
AP (1) AP497A (enEXAMPLES)
AT (1) ATE198275T1 (enEXAMPLES)
AU (1) AU683423B2 (enEXAMPLES)
BG (1) BG62317B1 (enEXAMPLES)
BR (1) BR9305642A (enEXAMPLES)
CA (1) CA2122827A1 (enEXAMPLES)
CZ (1) CZ284806B6 (enEXAMPLES)
DE (1) DE69329790D1 (enEXAMPLES)
DZ (1) DZ1717A1 (enEXAMPLES)
EC (1) ECSP930986A (enEXAMPLES)
FI (1) FI942272L (enEXAMPLES)
FR (1) FR2695826B1 (enEXAMPLES)
HU (1) HUT67044A (enEXAMPLES)
IL (1) IL107039A (enEXAMPLES)
MA (1) MA22978A1 (enEXAMPLES)
NO (1) NO306238B1 (enEXAMPLES)
OA (1) OA09924A (enEXAMPLES)
PL (1) PL176120B1 (enEXAMPLES)
RO (1) RO115783B1 (enEXAMPLES)
RU (1) RU2120797C1 (enEXAMPLES)
SK (1) SK54694A3 (enEXAMPLES)
TN (1) TNSN93104A1 (enEXAMPLES)
TW (1) TW381024B (enEXAMPLES)
WO (1) WO1994006437A1 (enEXAMPLES)
YU (1) YU60493A (enEXAMPLES)
ZA (1) ZA936964B (enEXAMPLES)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ATE355854T1 (de) 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
KR100954741B1 (ko) 2001-06-29 2010-04-27 메드 그래프트 마이크로텍 인코포레이션 생분해성 주사가능한 이식제 및 관련된 제조방법과 용도
EP1509182A4 (en) * 2002-05-31 2009-12-30 Titan Pharmaceuticals Inc IMPLANTABLE POLYMERS DEVICE FOR THE DELAYED RELEASE OF BUPRENORPHINE
MXPA05010450A (es) * 2003-03-31 2005-11-04 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
US20050031668A1 (en) * 2003-05-30 2005-02-10 Patel Rajesh A. Implantable polymeric device for sustained release of nalmefene
ES2377932T3 (es) 2003-10-10 2012-04-03 Ferring Bv Formulación farmacéutica transdérmica para minimizar los residuos sobre la piel
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
BR9305642A (pt) 1996-01-09
RU2120797C1 (ru) 1998-10-27
US5565443A (en) 1996-10-15
DZ1717A1 (fr) 2002-02-17
NO941900D0 (no) 1994-05-20
KR100255700B1 (ko) 2000-08-01
SK54694A3 (en) 1994-10-05
CA2122827A1 (fr) 1994-03-31
EP0613372A1 (fr) 1994-09-07
BG62317B1 (bg) 1999-08-31
CN1094284A (zh) 1994-11-02
WO1994006437A1 (fr) 1994-03-31
RO115783B1 (ro) 2000-06-30
FR2695826B1 (fr) 1995-01-06
CZ116494A3 (en) 1995-03-15
ATE198275T1 (de) 2001-01-15
CZ284806B6 (cs) 1999-03-17
HUT67044A (en) 1995-01-30
EP0613372B1 (fr) 2000-12-27
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
TNSN93104A1 (fr) 1994-03-17
ECSP930986A (es) 1994-04-12
CN1095667C (zh) 2002-12-11
FI942272A0 (fi) 1994-05-16
DE69329790D1 (de) 2001-02-01
IL107039A0 (en) 1993-12-28
AU683423B2 (en) 1997-11-13
FI942272A7 (fi) 1994-05-16
YU60493A (sh) 1997-01-08
TW381024B (en) 2000-02-01
MA22978A1 (fr) 1994-04-01
AP497A (en) 1996-05-28
FR2695826A1 (fr) 1994-03-25
FI942272L (fi) 1994-05-16
HU9401395D0 (en) 1994-08-29
AU4822993A (en) 1994-04-12
AP9300576A0 (enEXAMPLES) 1993-10-31
IL107039A (en) 1999-01-26
ZA936964B (en) 1994-04-14
OA09924A (fr) 1994-09-15
NO306238B1 (no) 1999-10-11
BG98776A (bg) 1995-02-28

Similar Documents

Publication Publication Date Title
PL176120B1 (pl) Środek farmaceutyczny będący implantem podskórnym i sposób wytwarzania środka farmaceutycznego będącego implantem podskórnym.
DK2905014T3 (en) An intrauterine delivery system for contraception
US4346709A (en) Drug delivery devices comprising erodible polymer and erosion rate modifier
DE69522409T2 (de) Subkutan implantierbare Vorrichtung
EP1488784B1 (en) Male contraceptive implant
IL116433A (en) INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
NZ501236A (en) Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath
HU223690B1 (hu) Szilikonmaggal rendelkező hosszan tartóan androgént adagoló implantátum
Kind et al. Sustained release hormonal preparations
CA2927750A1 (en) Intrauterine delivery system
IL142524A (en) A device for administering drugs, especially for the delivery of androgens
EP0052916A2 (en) Erodible polymer containing erosion rate modifier
Sam Controlled release contraceptive devices: a status report
EP2062569B1 (en) Vaginal delivery system
Singh et al. Biodegradable norethindrone (NET: cholesterol) contraceptive implants: Phase II-A: A clinical study in women
Moo-Young et al. Patent: Male contraceptive implant